Clinical Trial Update: Hydroxychloroquin (HCQ) in chILD of Genetic Defect [NA]

View source ↗

Summary

A ClinicalTrials.gov update notes the completion of a study testing hydroxychloroquine for surfactant dysfunction-related childhood interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surfactant Dysfunction

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Surfactant Dysfunction | NA | Status: COMPLETED